Terramed
2 extracted findings
FDA source excerpt, selected passage
“Genital Herpes Intimate Wash,” “HerpCare Ointment,” “HerpCare Spray,” and “HerpCare Genital Wart Remover Ointment” are drugs under section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or intended to affect the structure or any function of the body.
Findings and supporting evidence
Model-assisted readings, not an exhaustive interpretation. Compare with the extracted source findings below.
Findings extracted from the letter
Selected FDA passages, not the complete letter.
01
“Genital Herpes Intimate Wash,” “HerpCare Ointment,” “HerpCare Spray,” and “HerpCare Genital Wart Remover Ointment” are drugs under section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or intended to affect the structure or any function of the body.
Source passage selected by the model
02
No approved applications pursuant to section 505 of the FD&C Act, 21 U.S.C. 355, are in effect for these products.
Source passage selected by the model
Sections and clauses cited
As cited in this historical letter, not a statement of current regulatory requirements.